gene therapy product retroviral vector

Biobanking Science: Safe Gene Therapy

Gene therapy has the potential to cure any disease caused by genetic mutations. For gene therapy to work, normal copies of genetic DNA, replacement messenger RNA or gene-editing constructs must be delivered to affected cells. Nucleic acids are rapidly...

30 Minute Webinar: Biospecimen Quality for Precision Medicine Hosted By CloudLIMS

Tuesday, September 25, 2018 | 10:00 AM PDT |1:00 PM EDT | 5:00 PM GMT Presented by Dr. Jim Vaught, Editor-in-Chief of Biopreservation and Biobanking (BIO), the official journal of ISBER. Who is it for? CloudLIMS encourages laboratory directors, managers and...

ESPERITE Announced A New Geneva BioBank With Capacity For More Than A Million Samples

ESPERITE is a diversified biotech global group leader in regenerative and precision medicine. Established in 2000, the holding group is headquartered in the Netherlands, listed at Euronext Amsterdam and Paris and operational in over 30 countries. ESPERITE transforms the power...

Coriell Institute Selects InformedDNA To Provide Genetic Counseling Services

InformedDNA®, has been selected by the Coriell Institute for Medical Research to provide genetic counseling services to participants in the Coriell Personalized Medicine Collaborative (CPMC) research study. The Coriell Institute, founded in 1953, located in the Greater Philadelphia area is...
metabolomics needs biobanks

Biobanking Science: Metabolomics Biobanks

Metabolomics, an important part of precision medicine, is the study of different metabolites in normal and disease states. Collecting, processing and storing samples for metabolomics studies presents unique challenges for biobanks. Metabolites are small (low molecular weight) and unstable molecules....

Towards A Global Effort: Nightingale To Analyse Mexico City Prospective Study Blood Samples

Founded in 2013, Nightingale Health is a Finnish biotech company aiming to solve the world’s number one health issue - chronic diseases. With a proprietary blood analysis platform, the company can improve risk prediction of diseases such as cardiovascular...

Bluechiip Raised $5.5 Million Following Updated Agreement With Labcon North America

Bluechiip has announced that it has successfully raised $5.5 million via an oversubscribed placement to sophisticated and professional investors. Bluechiip Ltd, founded in 2003, based in Australia, has developed a wireless tracking solution for the healthcare and life science, security,...

Bone Therapeutics Provides 2018 Half Year Update Including ALLOB® Allogeneic Cell Therapy Product

Bone Therapeutics is a leading cell therapy company, founded in 2006, addressing high unmet needs in orthopaedics and bone diseases. Based in Gosselies, Belgium, the Company has a broad, diversified portfolio of bone cell therapy products in clinical development...
Cancer biobanks aid research

Biobanking Science: Cancer Biobanks

Cancer is major cause of death worldwide and mortality levels remain high despite the development of new therapeutics and other cancer treatments. Cancer biobanks are an integral part of the fight against cancer because they facilitate research into new...

Cynata’s CYP-001 Stem Cell Therapy Meets Expectations In Phase 1 Graft-Versus-Host Disease Trial

Cynata Therapeutics Limited is an Australian clinical-stage stem cell and regenerative medicine company founded in 2003 that is developing a therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader in stem cell research. CYP-001,...